论文部分内容阅读
目的:研究观察中药配合人工肝血浆置换支持系统治疗重型病毒性肝炎疗效。方法:将102例重型病毒性肌炎患者随机分为治疗组与对照组,两组均采用相似的内科支持对症治疗的基础上,治疗组46例加用中药治疗,同时比较两组患者临床症状改善效果,2周后的各项生化指标,2月内并发症发生率,1月内生存率。结果:治疗组大部分患者临床症状明显改善,肝功指标好转,预防感染、出血、肝性脑病及肝肾综合征等方面均明显优于对照组(p<0.05),近期生存率明显高于对照组(p<0.05)。结论:中西医结合优势互补,顿挫病势,提高重型肝炎的抢救成功率,是值得探索研究的重要问题。
Objective: To observe the curative effect of traditional Chinese medicine and artificial liver plasma exchange support system on severe viral hepatitis. Methods: A total of 102 patients with severe viral myositis were randomly divided into treatment group and control group. The two groups were treated with similar medical support symptomatic treatment. The treatment group received 46 cases plus traditional Chinese medicine, and the clinical symptoms Improve the effect, two weeks after the biochemical indicators, the incidence of complications in February, January survival rate. Results: The clinical symptoms of most patients in the treatment group were significantly improved, the improvement of liver function, prevention of infection, hemorrhage, hepatic encephalopathy and hepatorenal syndrome were significantly better than those in the control group (p <0.05), and the recent survival rate was significantly higher Control group (p <0.05). Conclusion: The combination of traditional Chinese and western medicine has the advantages of complementarity, defeat the disease and improve the success rate of rescue of severe hepatitis, which is worth to explore the important issue.